Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 244

1.

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.

Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, Issachar A, Mor E, Sarfaty M, Bragilovski D, Hur RB, Gordon N, Stemmer SM, Allen AM.

Radiat Oncol. 2017 Oct 19;12(1):163. doi: 10.1186/s13014-017-0899-4.

2.

Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience.

Green H, Lichtenberg S, Rahamimov R, Livneh A, Chagnac A, Mor E, Rozen-Zvi B.

Transplantation. 2017 Oct;101(10):2621-2626. doi: 10.1097/TP.0000000000001681.

PMID:
28926523
3.

Posttransplantation anemia in kidney transplant recipients: A retrospective cohort study.

Gafter-Gvili A, Ayalon-Dangur I, Cooper L, Shochat T, Rahamimov R, Gafter U, Mor E, Grossman A.

Medicine (Baltimore). 2017 Aug;96(32):e7735. doi: 10.1097/MD.0000000000007735.

4.

New onset diabetes after kidney transplantation is associated with increased mortality-A retrospective cohort study.

Cooper L, Oz N, Fishman G, Shohat T, Rahamimov R, Mor E, Green H, Grossman A.

Diabetes Metab Res Rev. 2017 Nov;33(8). doi: 10.1002/dmrr.2920. Epub 2017 Aug 30.

PMID:
28731619
5.

[ABO INCOMPATIBLE KIDNEY TRANSPLANTATION].

Eisner S, Orlin J, Nesher E, Mazhybovsky V, Gurevich M, Michowiz R, Rahamimov R, Mor E.

Harefuah. 2017 Apr;156(4):237-241. Hebrew.

PMID:
28551928
6.

The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation.

Lichtenberg S, Rahamimov R, Green H, Fox BD, Mor E, Gafter U, Chagnac A, Rozen-Zvi B.

Eur J Clin Pharmacol. 2017 Jul;73(7):819-826. doi: 10.1007/s00228-017-2234-2. Epub 2017 Mar 24.

PMID:
28342067
7.

Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?

Nesher E, Mor E, Shlomai A, Naftaly-Cohen M, Yemini R, Yussim A, Brown M, Keidar A.

Obes Surg. 2017 May;27(5):1387-1390. doi: 10.1007/s11695-017-2634-5.

PMID:
28281236
8.

The Impact of Bariatric Surgery on Thyroid Function and Medication Use in Patients with Hypothyroidism.

Zendel A, Abu-Ghanem Y, Dux J, Mor E, Zippel D, Goitein D.

Obes Surg. 2017 Aug;27(8):2000-2004. doi: 10.1007/s11695-017-2616-7.

PMID:
28255851
9.

Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.

Leibovici-Weissman Y, Mor E, Leshno M, Shlomai A.

Dig Dis Sci. 2017 Mar;62(3):801-807. doi: 10.1007/s10620-016-4423-8. Epub 2017 Jan 4.

PMID:
28054162
10.

Association of the combination of time-weighted variability of tacrolimus blood level and exposure to low drug levels with graft survival after kidney transplantation.

Rozen-Zvi B, Schneider S, Lichtenberg S, Green H, Cohen O, Gafter U, Chagnac A, Mor E, Rahamimov R.

Nephrol Dial Transplant. 2017 Feb 1;32(2):393-399. doi: 10.1093/ndt/gfw394.

PMID:
28025383
11.

Serum Lactate Dehydrogenase is Elevated in Ischemic Acute Tubular Necrosis but Not in Acute Rejection in Kidney Transplant Patients.

Green H, Tobar A, Gafter-Gvili A, Leibovici L, Klein T, Rahamimov R, Mor E, Grossman A.

Prog Transplant. 2017 Mar;27(1):53-57. doi: 10.1177/1526924816664089. Epub 2016 Sep 20.

PMID:
27555073
12.

Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.

Cleper R, Krause I, Bar Nathan N, Mor M, Dagan A, Weissman I, Frishberg Y, Rachamimov R, Mor E, Davidovits M.

Clin Transplant. 2016 Oct;30(10):1324-1331. doi: 10.1111/ctr.12825.

PMID:
27490751
13.

Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience.

Moore A, Cohen-Naftaly M, Benjaminov O, Braun M, Issachar A, Mor E, Tovar A, Sarfaty M, Gordon N, Stemmer SM.

J Cancer. 2016 Apr 29;7(8):883-9. doi: 10.7150/jca.14721. eCollection 2016.

14.

Cytomegalovirus-negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation.

Rozen-Zvi B, Lichtenberg S, Green H, Cohen O, Chagnac A, Mor E, Rahamimov R.

Clin Transplant. 2016 Sep;30(9):980-5. doi: 10.1111/ctr.12775. Epub 2016 Jul 6.

PMID:
27286324
15.

Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donors.

Grossman A, Koren R, Tirosh A, Michowiz R, Shohat Z, Rahamimov R, Mor E, Shimon I, Robenshtok E.

Endocr Res. 2016 May;41(2):98-102. doi: 10.3109/07435800.2015.1076455. Epub 2015 Nov 5.

PMID:
26541634
16.

The impact of the israeli transplantation law on the socio-demographic profile of living kidney donors.

Boas H, Mor E, Michowitz R, Rozen-Zvi B, Rahamimov R.

Am J Transplant. 2015 Apr;15(4):1076-80. doi: 10.1111/ajt.13090. Epub 2015 Mar 3.

17.

Organ donation in Israel--achievements and challenges.

Ashkenazi T, Lavee J, Mor E.

Transplantation. 2015 Feb;99(2):265-6. doi: 10.1097/TP.0000000000000591. No abstract available.

PMID:
25651113
18.

Cluster-enhanced sparse approximation of overlapping ultrasonic echoes.

Mor E, Aladjem M, Azoulay A.

IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Feb;62(2):373-86. doi: 10.1109/TUFFC.2014.006769.

PMID:
25643086
19.

Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience.

Green H, Rahamimov R, Rozen-Zvi B, Pertzov B, Tobar A, Lichtenberg S, Gafter U, Mor E.

Transplantation. 2015 Jun;99(6):1172-7. doi: 10.1097/TP.0000000000000459.

PMID:
25340602
20.

MicroRNA-34a is dispensable for p53 function as teratogenesis inducer.

Mor E, He L, Torchinsky A, Shomron N.

Arch Toxicol. 2014 Sep;88(9):1749-63. doi: 10.1007/s00204-014-1223-9. Epub 2014 Mar 13.

PMID:
24623309

Supplemental Content

Loading ...
Support Center